{"title":"扩大药师处方权限对COVID-19疫苗接种率的影响","authors":"Taylor Le, Thomas Kelly","doi":"10.24926/iip.v16i1.6126","DOIUrl":null,"url":null,"abstract":"<p><p><i>Background</i>: Recent legislatures have granted expanded prescriptive authority to pharmacists with a collaborative practice agreement with a physician. This authority could include prescribing tobacco cessation products, birth controls, and antivirals for COVID-19. Although closely associated with providing preventative measures for COVID-19 in the forms of testing and vaccinations, the relationship between pharmacist prescriptive power and rate of COVID-19 vaccination remains unexplored. The objective of the study is to determine the association between pharmacist prescriptive authority and the rate of COVID-19 vaccinations between neighboring counties along state lines of states with differing laws on this prescriptive power. <i>Methods</i>: States with expanded pharmacist prescriptive authority include: New Mexico, Oregon, Idaho, Florida, California, North Carolina, Montana, New York, Iowa, Massachusetts, and Ohio. Counties are selected if the center of the county is within 30 miles from a state border that divides a state with expanded pharmacist prescriptive authority from a state without. Monthly vaccination data from January 2021 to December 2021 was acquired from the Centers for Disease Control and Prevention and linear regression was performed and state-border-pair fixed effects was used as a control. <i>Results</i>: The estimated effect of expanded prescriptive authority is an increase of five percentage points in the share of the adult population that completed the initial COVID-19 vaccine series. <i>Conclusion</i>: The relationship between pharmacist prescriptive authority and increased COVID-19 vaccination rates is statistically significant. The results showed that allowing pharmacist to have prescriptive powers could potentially aid in reducing vaccine hesitancy for future pandemics.</p>","PeriodicalId":501014,"journal":{"name":"Innovations in pharmacy","volume":"16 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12509719/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Effect of Expanded Pharmacist Prescriptive Authority on COVID-19 Vaccine Rates.\",\"authors\":\"Taylor Le, Thomas Kelly\",\"doi\":\"10.24926/iip.v16i1.6126\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><i>Background</i>: Recent legislatures have granted expanded prescriptive authority to pharmacists with a collaborative practice agreement with a physician. This authority could include prescribing tobacco cessation products, birth controls, and antivirals for COVID-19. Although closely associated with providing preventative measures for COVID-19 in the forms of testing and vaccinations, the relationship between pharmacist prescriptive power and rate of COVID-19 vaccination remains unexplored. The objective of the study is to determine the association between pharmacist prescriptive authority and the rate of COVID-19 vaccinations between neighboring counties along state lines of states with differing laws on this prescriptive power. <i>Methods</i>: States with expanded pharmacist prescriptive authority include: New Mexico, Oregon, Idaho, Florida, California, North Carolina, Montana, New York, Iowa, Massachusetts, and Ohio. Counties are selected if the center of the county is within 30 miles from a state border that divides a state with expanded pharmacist prescriptive authority from a state without. Monthly vaccination data from January 2021 to December 2021 was acquired from the Centers for Disease Control and Prevention and linear regression was performed and state-border-pair fixed effects was used as a control. <i>Results</i>: The estimated effect of expanded prescriptive authority is an increase of five percentage points in the share of the adult population that completed the initial COVID-19 vaccine series. <i>Conclusion</i>: The relationship between pharmacist prescriptive authority and increased COVID-19 vaccination rates is statistically significant. The results showed that allowing pharmacist to have prescriptive powers could potentially aid in reducing vaccine hesitancy for future pandemics.</p>\",\"PeriodicalId\":501014,\"journal\":{\"name\":\"Innovations in pharmacy\",\"volume\":\"16 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12509719/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Innovations in pharmacy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24926/iip.v16i1.6126\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innovations in pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24926/iip.v16i1.6126","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
The Effect of Expanded Pharmacist Prescriptive Authority on COVID-19 Vaccine Rates.
Background: Recent legislatures have granted expanded prescriptive authority to pharmacists with a collaborative practice agreement with a physician. This authority could include prescribing tobacco cessation products, birth controls, and antivirals for COVID-19. Although closely associated with providing preventative measures for COVID-19 in the forms of testing and vaccinations, the relationship between pharmacist prescriptive power and rate of COVID-19 vaccination remains unexplored. The objective of the study is to determine the association between pharmacist prescriptive authority and the rate of COVID-19 vaccinations between neighboring counties along state lines of states with differing laws on this prescriptive power. Methods: States with expanded pharmacist prescriptive authority include: New Mexico, Oregon, Idaho, Florida, California, North Carolina, Montana, New York, Iowa, Massachusetts, and Ohio. Counties are selected if the center of the county is within 30 miles from a state border that divides a state with expanded pharmacist prescriptive authority from a state without. Monthly vaccination data from January 2021 to December 2021 was acquired from the Centers for Disease Control and Prevention and linear regression was performed and state-border-pair fixed effects was used as a control. Results: The estimated effect of expanded prescriptive authority is an increase of five percentage points in the share of the adult population that completed the initial COVID-19 vaccine series. Conclusion: The relationship between pharmacist prescriptive authority and increased COVID-19 vaccination rates is statistically significant. The results showed that allowing pharmacist to have prescriptive powers could potentially aid in reducing vaccine hesitancy for future pandemics.